Loading…

Edwards Lifesciences announced National Technology Park, Castletroy, Limerick as the site for a new 170,000-square-foot manufacturing facility for transcatheter heart valve therapy components. The €80 million investment is expected to employ approximately 600 people and be operational by 2021.
“Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced National Technology Park, Castletroy, Limerick, as the location of its new permanent facility which is expected to manufacture delivery compon”enterprise.gov.ie
Summarized from public sources; check the original articles before acting on it.